BMP2 Diminishes Angiotensin II-Induced Atrial Fibrillation by Inhibiting NLRP3 Inflammasome Signaling in Atrial Fibroblasts
Biomolecules · 25.08.2024 · 14 (9) · 1053
DOI: 10.3390/biom14091053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 25.08.2024. Verfasst von Yue Yuan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Angiotensin II, Atrial Fibrillation, Bone Morphogenetic Protein 2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: First Affiliated Hospital of Harbin Medical University, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Atrial fibrillation (AF) is the most common sustained arrhythmia to affect 1% of the global population and increases with age. Atrial fibrosis is a crucial substrate for promoting structural remodeling to cause atrial arrhythmogenesis. Bone morphogenic protein 2 (BMP2) has been reported to be involved in cardiac fibrogenesis. However, its role in modulating atrial fibrosis to affect AF development remains unknown. Our study aimed to investigate the expression of BMP2 under different AF conditions and the effect of BMP2 on the progression of atrial fibrosis using an angiotensin II (Ang II) rat model and an ex vivo cardiac fibroblast model. The qRT-PCR and Western blot assay showed increased BMP2 mRNA and protein levels in the atria of chronic AF patients and the right atria of a tachypacing rabbit model. In contrast, the levels of BMP2 receptor mRNA were comparable. The AF incidence of the Ang II rat was higher than that of a control rat, which was reduced by BMP2 treatment. Masson staining demonstrated an anti-fibrogenic impact on BMP2-subjected rat atria compared to only Ang II-treated rat atria. RNA-sequencing indicated the potential function of blocking NLRP3-associted inflammasome activation in BMP2-treated rat atrial tissues. In vitro, transfecting BMP2 shRNA into neonatal rat atrial fibroblasts upregulated the mRNA levels of NLRP3/Caspase-1/p20/ASC and the secretion of IL-1β and IL-6. In contrast, recombinant BMP2 protein attenuated the increased levels of the NLRP3 inflammasome pathway induced by Ang II. In summary, BMP2 opposes atrial fibrosis to alleviate AF susceptibility by inhibiting the activation of the inflammasome in atrial fibroblasts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
- Department of General Medicine, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
ORCID-Profile: Yue Yuan
Förderung
- First Affiliated Hospital of Harbin Medical University
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Yuan, Y., Zhang, H., Xia, E., Zhao, X., Gao, Q., Mu, H., Liu, X., Tian, Y., Liu, L., Shen, Q., & Sheng, L. (2024). BMP2 Diminishes Angiotensin II-Induced Atrial Fibrillation by Inhibiting NLRP3 Inflammasome Signaling in Atrial Fibroblasts. Biomolecules, 14(9), 1053. https://doi.org/10.3390/biom14091053
Vancouver
Yuan Y, Zhang H, Xia E, Zhao X, Gao Q, Mu H, et al. BMP2 Diminishes Angiotensin II-Induced Atrial Fibrillation by Inhibiting NLRP3 Inflammasome Signaling in Atrial Fibroblasts. Biomolecules. 2024;14(9):1053. doi:10.3390/biom14091053
BibTeX
@article{Yuan2024,
author = {Yuan, Yue and Zhang, Hang and Xia, Erwen and Zhao, Xinbo and Gao, Qiang and Mu, Hongyuan and Liu, Xingzuo and Tian, Yuanye and Liu, Lei and Shen, Qiuling and Sheng, Li},
title = {BMP2 Diminishes Angiotensin II-Induced Atrial Fibrillation by Inhibiting NLRP3 Inflammasome Signaling in Atrial Fibroblasts},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {9},
pages = {1053},
doi = {10.3390/biom14091053}
}
EUVIMED